OKYO,OKYO Pharma Limited | Healthcare

Healthcare

OKYO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

OKYO Pharma LimitedOKYO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.

The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain.

The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Latest News >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Capital One Spark Cash Plus vs. Chase Ink Business Cash

Jul 25, 2025

Key takeaways The Capital One Spark Cash Plus and Ink Business Cash(R) Credit Card from Chase are both solid cash back cards for small business owners. The Capital One Spark Cash Plus is a better fit for high spenders (over $150,000 per year) who don't mind paying an annual fee and are able to pay their balance in full each...

Assessing Karooooo: Insights From 4 Financial Analysts

Jul 25, 2025

Across the recent three months, 4 analysts have shared their insights on Karooooo ( KARO ) , expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...

KLA's Options: A Look at What the Big Money is Thinking

Jul 25, 2025

Investors with a lot of money to spend have taken a bullish stance on KLA . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with KLAC,...